Research and Development

Showing 15 posts of 9599 posts found.

Huge increase in emerging market spending to lift pharma

July 16, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, IMS, emerging markets, pharmerging

The global pharmaceutical market is set to return to stronger growth of 5-7% by 2016, according to a new forecast. …

GSK and Theravance file COPD drug

July 16, 2012 Research and Development, Sales and Marketing EMA, GSK, Relovair, Revlar, Spiriva, Theravance

GlaxoSmithKline and US biopharma firm Theravance have submitted their investigational chronic obstructive pulmonary disease (COPD) drug to regulators in Europe …

AZ sets up Alzheimer’s research collaborative

July 13, 2012 Research and Development Alzheimer's, AstraZeneca, neuroscience

AstraZeneca and Dr Steven Paul of Weill Cornell Medical College have unveiled a new research alliance that brings four leading …
astrazeneca image

AstraZeneca buys neuroscience molecules

July 13, 2012 Research and Development Alzheimer's, AstraZeneca, neuroscience

AstraZeneca is to acquire a portfolio of neuroscience assets from Link Medicine, a private US pharma firm.The deal is the …
rob_gallo_takeda

Takeda appoints new head of Corporate Communications, Europe and Canada

July 12, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, communications

Takeda Pharmaceuticals has appointed Rob Gallo as head of Corporate Communications, Europe and Canada. Since 2010 Gallo has been the …
drbarbarahakin

NHS appoints first CSS managing directors

July 12, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hakin, NHS

The first round of appointments to commissioning support service (CSS) managing director posts has been made by the NHS Commissioning …
Actelion image

Jobs under threat in Actelion cost saving

July 12, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Actelion, R&D, Tracleer, cuts

Swiss speciality pharmaceutical company Actelion has unveiled a new cost saving plan which could include the loss of 260 jobs …

Amakem appoints new head of CMC and Operations

July 12, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing

Belgium-based Amakem NV has announced the appointment of Maarten van Geffen as head of CMC and Operations. The kinase platform …
Janssen image

Janssen buys into regenerative diabetes portfolio

July 11, 2012 Research and Development, Sales and Marketing CureBeta, Evotec, Janssen, diabetes

Janssen has licensed a portfolio of drugs designed to regenerate insulin-producing beta cells. Janssen will receive exclusive access to a …

Blow for BioInvent as vascular treatment fails

July 11, 2012 Research and Development, Sales and Marketing BI-204, BioInvent, LDL, Sweden

Swedish biotech company BioInvent has suffered a new blow with the failure of its lead pipeline candidate.  The company’s share …

Significant reorganisation for Chelsea Therapeutics

July 11, 2012 Research and Development, Sales and Marketing Chelsea Therapeutics, Northera, biopharma, biotech

Biopharma development firm Chelsea Therapeutics has announced a major corporate reorganisation. The move includes a significant reduction in headcount, the …

New chief executive for Daiichi Sankyo Europe

July 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daiichi Sankyo

Jan Van Ruymbeke has been appointed as the new chief executive of Daiichi Sankyo Europe from October. Van Ruymbeke, from Belgium, …

R&D, East & West: Lilly invests in its global research network

July 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asia, China, R&D, diabetes, lilly

Eli Lilly officially opened its new research facilities at its R&D base in Erl Wood in Surrey in April. The …
Xarelto image

Priority review for Xarelto’s new indications

July 10, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Boehringer, Eliquis, FDA, Janssen, Pradaxa, Xarelto

Xarelto is to be given a FDA fast-track review for a range of anti-blood clotting uses. Xarelto (rivaroxaban) gained its …
louferrari

Savient appoints new president and chief executive

July 10, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Ferrari, Savient, cuts

Savient Pharmaceuticals has appointed Louis Ferrari to the role of president and chief executive for the firm. Ferrari succeeds Savient’s …
The Gateway to Local Adoption Series

Latest content